The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Psychiatric Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jpsychires.2008.04.009PMID 18533184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

  2007cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Ethyl-Eicosapentaenoate for depression with melancholic features

  2005cited by this paper
• Creatine supplementation lowers brain glutamate levels in Huntington’s disease

  2005cited by this paper
• Relative Antidepressant Efficacy of Venlafaxine and SSRIs: Sex-Age Interactions

  2005cited by this paper
• Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.

  2005cited by this paper
• Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study.

  2005cited by this paper
• Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.

  2004cited by this paper
• Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression

  2003influential reference
• Pharmacological and Nonpharmacological Factors Influencing Hypothalamic–Pituitary–Adrenocortical Axis Reactivity in Acutely Depressed Psychiatric In-patients, Measured by the Dex-CRH Test

  2003cited by this paper
• Effect of 38 h of total sleep deprivation on the waking EEG in women: sex differences.

  2003cited by this paper
• Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression

  2003cited by this paper
• Neurotrophic Effects of Electroconvulsive Therapy: A Proton Magnetic Resonance Study of the Left Amygdalar Region in Patients with Treatment-Resistant Depression

  2003influential reference
• State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine

  2003cited by this paper
• Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients.

  2003influential reference
• Low-dose dexamethasone challenge in women with atypical major depression: pilot study.

  2002cited by this paper
• Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

  2002cited by this paper
• Increase in Amino Acids in the Pons after Sleep Deprivation: A Pilot Study Using Proton Magnetic Resonance Spectroscopy

  2002cited by this paper
• Toward validation of atypical depression in the community: results of the Zurich cohort study.

  2002cited by this paper
• Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

  2000cited by this paper
• Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls - part I: the sleep eeg.

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper
• Sexually dimorphic effects of GHRH on sleep-endocrine activity in patients with depression and normal controls - part II: hormone secretion.

  2000cited by this paper
• Gender differences in treatment response to sertraline versus imipramine in chronic depression.

  2000cited by this paper
• Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

  1999cited by this paper
• Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

  1999cited by this paper
• Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.

  1998cited by this paper
• Interleukin-1 beta and tumor necrosis factor-alpha suppress dexamethasone induction of glutamine synthetase in primary mouse astrocytes.

  1998cited by this paper
• Interleukin‐1β and Tumor Necrosis Factor‐α Suppress Dexamethasone Induction of Glutamine Synthetase in Primary Mouse Astrocytes

  1998cited by this paper
• Paradoxical sleep deprivation increases the content of glutamate and glutamine in rat cerebral cortex.

  1996cited by this paper
• GABA and mood disorders: a brief review and hypothesis.

  1995cited by this paper
• Benzodiazepines as antidepressants: does GABA play a role in depression?

  1995cited by this paper
• Glutamine synthetase gene experession in a glioblastoma cell-line of clonal origin: Regulation by dexamethasone and dibutyryl cyclic AMP

  1995cited by this paper
• The relationship between tiredness prior to sleep deprivation and the antidepressant response to sleep deprivation in depression.

  1995cited by this paper
• Transcriptional control of glial fibrillary acidic protein and glutamine synthetase in vivo shows opposite responses to corticosterone in the hippocampus.

  1994cited by this paper
• Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder

  1987cited by this paper
• The dexamethasone suppression test as a predictor of sleep deprivation antidepressant effect.

  1982cited by this paper
• Use of the Hamilton Rating Scale for classification of depressive disorders.

  1982cited by this paper
• Potentiation of ketamine effects on the spiking activity in the lateral geniculate nucleus by rapid eye movement (REM) sleep deprivation.

  1976cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960influential reference

• Sleep phase delay exacerbates treatment resistance in obsessive-compulsive disorder via elevated anterior cingulate cortex glutamate: A mediation analysis.

  2026cites this paper
• Integrating plasma metabolomics using UPLC-Q Exactive Orbitrap HRMS and targeted amino acid and neurotransmitter analysis in plasma and cerebrospinal fluid by LC-MS/MS to explore biomarkers in pregnancy women with insomnia.

  2026cites this paper
• Impact of Spaceflight Stressors on Behavior and Cognition: a Molecular, Neurochemical, and Neurobiological Perspective.

  2022cites this paper
• Rapid treatments for depression: Endocannabinoid system as a therapeutic target.

  2022cites this paper
• A viewpoint on aldosterone and BMI related brain morphology in relation to treatment outcome in patients with major depression

  2022cites this paper
• Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

  2022cites this paper
• A continuum hypothesis of psychotomimetic rapid antidepressants

  2021cites this paper
• The role of sleep disturbances in depressive-like behavior with emphasis on α-ketoglutarate dehydrogenase activity in rats.

  2020cites this paper
• Ventricular volume, white matter alterations and outcome of major depression and their relationship to endocrine parameters – A pilot study

  2020cites this paper
• Neuroglia Molecular Mechanisms in Psychiatric Disorders

  2019cites this paper
• Augmentation of Pharmacotherapy by Sleep Deprivation with Sleep Phase Advance in Treatment-Resistant Depression

  2018cites this paper
• Dynamic changes in cerebral and peripheral markers of glutamatergic signaling across the human sleep–wake cycle

  2018cites this paper
• Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders

  2018cites this paper
• Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.

  2017cites this paper
• Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

  2017cites this paper
• Chronotherapeutics in Bipolar and Major Depressive Disorders: Implications for Novel Therapeutics

  2016cites this paper
• A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs

  2015cites this paper
• Magnetic Resonance Spectroscopy in Major Depressive Disorder

  2015influential citation
• Sleep deprivation as a method of chronotherapy in the treatment of depression.

  2015cites this paper
• Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

  2014cites this paper
• Delayed circadian phase is linked to glutamatergic functions in young people with affective disorders: a proton magnetic resonance spectroscopy study

  2014cites this paper
• Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons

  2014cites this paper
• Decreased Occipital Cortical Glutamate Levels in Response to Successful Cognitive-Behavioral Therapy and Pharmacotherapy for Major Depressive Disorder

  2014cites this paper
• Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review.

  2013cites this paper
• Ketamine, magnesium and major depression--from pharmacology to pathophysiology and back.

  2013cites this paper
• Human biomarkers of rapid antidepressant effects.

  2013cites this paper
• Neuroimaging Approaches to the Understanding of Depression and the Identification of Novel Antidepressants

  2013cites this paper
• ω-3 and major depression: a review

  2013cites this paper
• Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature.

  2012cites this paper
• Clinical Consequences of the Role of Glutamate and Neuroplasticity in Depressive Disorder

  2011cites this paper
• An update on the role of glutamate in the pathophysiology of depression

  2010cites this paper
• Effect of chronic administration of ketamine on the mitochondrial respiratory chain activity caused by chronic mild stress

  2010cites this paper
• Sleep deprivation in depression

  2010cites this paper
• Sleep deprivation in depression

  2010cites this paper
• Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress.

  2009cites this paper
• Current awareness in human psychopharmacology

  2009cites this paper
• Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controls.

  2009cites this paper
• Brain GABA levels in patients with bipolar disorder.

  2009cites this paper
• Antidepressants induce regionally discrete, sex-dependent changes in brain's glutamate content.

  2009cites this paper
• Current Awareness in NMR in Biomedicine

  2009cites this paper
• Treatment of patients comorbid with alcohol dependence and major depressive disorder with memantine and escitalopram - outcome and predictors

  2008cites this paper